Abbott Laboratories buy The Goldman Sachs Group, Inc.
Start price
23.01.26
/
50%
€92.26
Target price
23.01.27
€119.18
Performance (%)
0.24%
Price
20:50
€92.48
Summary
This prediction is currently active. The BUY prediction by The_Goldman_Sachs_Gr for Abbott Laboratories is nearly unchanged. This prediction currently runs until 23.01.27. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | 3.068% | 3.068% |
| iShares Core DAX® | 0.855% | 0.389% |
| iShares Nasdaq 100 | -0.989% | -4.400% |
| iShares Nikkei 225® | -1.781% | -11.216% |
| iShares S&P 500 | 0.057% | 0.778% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE:ABT) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $152.00 to $140.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€106.22
15.01.26
15.01.26
€130.60
15.01.27
15.01.27
-15.18%
20:50
20:50
Abbott Laboratories
Start price
Target price
Perf. (%)
€115.08
01.10.25
01.10.25
€133.73
01.10.26
01.10.26
-19.27%
20:50
20:50
Abbott Laboratories
Start price
Target price
Perf. (%)
€133.42
04.03.25
04.03.25
€146.25
04.03.26
04.03.26
-26.88%
05.03.26
05.03.26